Sort
39,280 grants matching “leukemia”
UG1 - NCTN (Network Lead)
$533,194Hedy L Kindler · University Of Chicago · UG1 · FY2022 · CA
Defining Epidrivers of CLL Evolution in Response to Targeted Therapy
$533,038Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
$532,884Anupriya Agarwal · Oregon Health & Science University · R01 · FY2021 · HL
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
$532,795David T Scadden · Dana-Farber Cancer Inst · U54 · FY2017 · CA
Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL
$532,785Brian Hess · Medical University Of South Carolina · R01 · FY2025 · CA
Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
$532,743Peter Kurre · Children'S Hosp Of Philadelphia · R01 · FY2020 · HL
Processed Antigen Characterization by Mass Spectrometry
$532,685Donald F Hunt · University Of Virginia · R01 · FY2012 · AI
Advancing Clinical Trails in Coastal North Carolina
$532,663Patrick D Maguire · New Hanover Regional Medical Center · U10 · FY2013 · CA
NCTN Deep South Research Consortium
$532,662Charles A. Leath · University Of Alabama At Birmingham · UG1 · FY2021 · CA
HOX cluster intergenic non-coding RNAs in myeloid differentiation and function
$532,604Peter E Newburger · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · DK
Deltaretrovirus Morphology and Particle Assembly
$532,594Louis M Mansky · University Of Minnesota · R01 · FY2025 · GM
BET bromodomain inhibition as targeted therapy in acute myeloid leukemia
$532,576Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2014 · CA
Targeting Leukemic Stem Cells
$532,557Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA
Analysis of Nematode Sex Determination
$532,528Barbara J Meyer · University Of California Berkeley · R01 · FY2011 · GM
Ethnic Differences in Survival after Childhood ALL
$532,508City Of Hope/Beckman Research Institute · R01 · FY2004 · CA
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
$532,355Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
$532,355Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
$532,355Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Tissue Core
$532,348Laura Z Rassenti · University Of California, San Diego · P01 · FY2013 · CA
Diazeniumdiolates as Broad-Spectrum Anticancer Agents
$532,298Larry K Keefer · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Transcriptional response to signaling during hematopoiesis
$532,262Leonard I Zon · Boston Children'S Hospital · R01 · FY2021 · HL
The Role of miR-142 in the Transformation of Clonal Hematopoietic Disorders into AML
$532,031Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Regulation of HTLV-I Transcription
$532,000John N. Brady · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
STAT3 inhibition as a therapeutic strategy against MDS stem cells
$531,973Amit Verma · Albert Einstein College Of Medicine · R01 · FY2021 · HL
STAT3 inhibition as a therapeutic strategy against MDS stem cells
$531,973Amit Verma · Albert Einstein College Of Medicine · R01 · FY2020 · HL